Literature DB >> 7356832

Revascularization for severe limb ischemia.

G D Perdue, R B Smith, C R Veazey, J D Ansley.   

Abstract

Patients with rest pain or tissue necrosis (generally correlated with a tibial-brachial pressure index of less than 0.25) have a high probability of limb loss unless revascularization is done. These problems are usually associated with extensive and multiple segments of anatomical occlusive disease. A review of 359 patients with such problems indicates that revascularization was done in 86%, with initial success in 92% of patients. The durability of successful limb preservation proved good, with 90% of patients having a comfortable, useful limb to time of death or for one year or longer after operation. Cumulative patency rates were 90% at five years for aortofemoral reconstructions, 70% at five years for femoropopliteal bypasses, and 49% at five years for femorotibial grafts. Cumulative limb salvage rates were 93%, 81%, and 67% at five years in the same categories, respectively.

Entities:  

Mesh:

Year:  1980        PMID: 7356832     DOI: 10.1001/archsurg.1980.01380020036009

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  3 in total

1.  Progress in limb salvage by reconstructive arterial surgery combined with new or improved adjunctive procedures.

Authors:  F J Veith; S K Gupta; R H Samson; L A Scher; S C Fell; P Weiss; G Janko; S W Flores; H Rifkin; G Bernstein; H Haimovici; M L Gliedman; S Sprayregen
Journal:  Ann Surg       Date:  1981-10       Impact factor: 12.969

2.  Changing arteriosclerotic disease patterns and management strategies in lower-limb-threatening ischemia.

Authors:  F J Veith; S K Gupta; K R Wengerter; J Goldsmith; S P Rivers; C W Bakal; A M Dietzek; J Cynamon; S Sprayregen; M L Gliedman
Journal:  Ann Surg       Date:  1990-10       Impact factor: 12.969

3.  Five year experience using PTFE vascular grafts for lower limb ischaemia.

Authors:  M R Williams; T Mikulin; J Lemberger; B R Hopkinson; G S Makin
Journal:  Ann R Coll Surg Engl       Date:  1985-05       Impact factor: 1.891

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.